My watch list
my.bionity.com  
Login  
NEWS
Current news

Long-Term Testosterone Therapy Does Not Increase the Risk of Prostate Cancer

Testosterone (T) therapy is routinely used in men with hypogonadism, a condition in which diminished function of the gonads occurs. Although there is no evidence that T therapy increases the risk of prostate cancer (PCa), there are still concerns and a paucity of long-term data. In a new st ... more

Aluminium in everyday life: a health risk?

Aluminium and its compounds are contained in numerous foods, cosmetics and other products. Scientists, the media and the public are currently debating whether there may be a connection between aluminium intake and diseases such as Alzheimer's and breast cancer. Does aluminium indeed cause i ... more

New guide to the genetic jungle of muscles can help health research

New guide to the genetic jungle of muscles can help health research Researchers from Aarhus University and Bispebjerg Hospital have created a comprehensive overview of how tens of thousands of genes interact in relation to the behavior of muscles. At the same time, they have developed a gui ... more

DNA survives critical entry into Earth's atmosphere

Applied to the outer shell of the payload section of a rocket using pipettes, small, double-stranded DNA molecules flew into space from Earth and back again. After the launch, space flight, re-entry into Earth's atmosphere and landing, the so-called plasmid DNA molecules were still found on ... more

SLU researcher finds an off switch for pain

In research published in the medical journal Brain, Saint Louis University researcher Daniela Salvemini, Ph.D. and colleagues within SLU, the National Institutes of Health (NIH) and other academic institutions have discovered a way to block a pain pathway in animal models of chronic neuropa ... more

Promethera Biosciences raises €25.33 million in Series C financial round

Promethera Biosciences announced the completion of its Series C fundraising round. The company has raised €25.33 million ($31.4 million), including €20.33 million in capital.  The financing round is supported by existing Promethera Biosciences investors and two new investors: SFPI-FPIM, the ... more

$1 Billion Oncology Alliance Initiates First-in-Human Study of Enhanced Antibody for Treatment of Acute Myeloid Leukemia

Oxford BioTherapeutics and Berlin Chemie/ Menarini Biotech/ Menarini Ricerche (belonging to Menarini Group) announced that they have initiated the first-in-human clinical study of OBT357 (MEN1112), an enhanced antibody for the treatment of acute myeloid leukemia (AML). This is the first of ... more

Merck Commissions Biomass Energy Plant in India

Merck commissioned a climate-neutral co-generation plant at its production site in Goa, India. In doing so, Merck is underscoring its commitment to climate protection and energy efficiency in line with its corporate responsibility. The project is part of a company-wide climate protection pr ... more

Apitope Receives Orphan Designation in the European Union for ATX-F8-117 for the treatment of Haemophilia A

Apitope announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has granted orphan medicinal product designation to ATX-F8-117 for the treatment of haemophilia A.Haemophilia A is a rare chronic bleeding disorder which leads to inadequate clotting of ... more

Trojan horse tactic gives parasites edge over immune systems

Parasites use Trojan horse subterfuge to suppress the immunity of their victims when causing infection, according to a study. The finding, which shows a new trick parasites can play, paves the way to possible treatments for infectious diseases and allergies. Scientists have shown that paras ... more

All news

Measuring Skin Rejuvenescence

Many people in the Western World consider it as a social need to hide the effects of aging. For this purpose, different cutaneous rejuvenation treatments have been developed, including a laser-based technique, known as laser resurfacing. Skin irradiation with high-power pulsed laser light i ... more

Dyax Corp. Recognized as a "Top Place to Work" by The Boston Globe

Dyax Corp. announced that it has been named one of the Top Places to Work in Massachusetts by The Boston Globe."Great people build great businesses. At Dyax, our employees are the foundation of our organization and are behind our steady growth and winning culture," said Gustav Christensen, ... more

Eurofins Genomics Achieves GLP Certification

Eurofins Genomics has now achieved Good Laboratory Practice (GLP) certification for DNA sequencing services, the first genomic service provider in Germany to attain such qualification.Good Laboratory Practice is a required standard for laboratories conducting non-clinical safety studies, fo ... more

Failed Alzheimer’s test shows in which direction the research should continue

Disappointing results in clinical Alzheimer’s studies discourage doctors and scientists from continuing their research into ɣ-secretases and a possible treatment against Alzheimer’s disease. In Cell, the Alzheimer’s expert Bart De Strooper (VIB-KU Leuven) argues that these studies are not p ... more

Nabsys Appoints Anthony Shuber as Chief Scientific Officer

Nabsys, Inc. announced today Anthony Shuber has joined the company as Vice President and Chief Scientific Officer. In this role, Shuber will lead the company’s efforts in product strategy as the company transitions its initial commercial focus toward oncology. Shuber, an industry veteran an ... more

New microscope collects dynamic images of the molecules that animate life

Over the last decade, powerful new microscopes have dramatically sharpened biologists' focus on the molecules that animate and propel life. Now, a new imaging platform developed by Eric Betzig and colleagues at the Howard Hughes Medical Institute's Janelia Research Campus offers another lea ... more

Eppendorf Award for Young European Investigators 2015: Call for entries

Until 15 January 2015, young researchers working in Europe who are not older than 35 years are invited to apply for the Eppendorf Award for Young European Investigators. This prize acknowledges outstanding contributions to biomedical research in Europe based on methods of molecular biology, ... more

Eurofins Genomics Extends Its Genomic Business Into Austria And Czech Republic

Eurofins Genomics, the genomics division of the Eurofins Scientific Group, has now established its own subsidiary in Austria. Customers will be served directly through Eurofins Genomics AT GmbH located in Vienna.The acquisition of the oligonucleotide synthesis and DNA sequencing businesses ... more

New sequencing reveals genetic history of tomatoes

An international team of researchers, led by the Chinese Academy of Agricultural Sciences in Beijing, published in the journal Nature Genetics a brief genomic history of tomato breeding, based on sequencing of 360 varieties of the tomato plant. The C.M. Rick Tomato Genetics Resource Center ... more

Eurofins Genomics Extends Its Genomic Business In Italy

Eurofins Genomics, the genomics division of the Eurofins Scientific Group, has now established its own subsidiary in Italy, located in Vimodrone, Milan. With the acquisition of the oligonucleotide synthesis and DNA sequencing business from Primm S.r.l. in June this year and the decision to ... more

All news on bioanalytics

New guide to the genetic jungle of muscles can help health research

New guide to the genetic jungle of muscles can help health research Researchers from Aarhus University and Bispebjerg Hospital have created a comprehensive overview of how tens of thousands of genes interact in relation to the behavior of muscles. At the same time, they have developed a gui ... more

DNA survives critical entry into Earth's atmosphere

Applied to the outer shell of the payload section of a rocket using pipettes, small, double-stranded DNA molecules flew into space from Earth and back again. After the launch, space flight, re-entry into Earth's atmosphere and landing, the so-called plasmid DNA molecules were still found on ... more

Has a possible new lead been found in the fight against neurodegenerative diseases?

Good communication between brain cells is vital for optimal (mental) health. Mutations in the TBC1D24 gene inhibit this process, thereby causing neurodegeneration and epilepsy. Fruit flies with a defect in Skywalker, the fruit fly variant of TBC1D24, are being used as a model for neurodegen ... more

Bone Therapeutics Appoints Dr Guy Heynen as Chief Clinical and Regulatory Officer

Bone Therapeutics announced the appointment of Dr Guy Heynen as Chief Clinical and Regulatory Officer. Dr Heynen will support Bone Therapeutics as it progresses its strong pipeline of regenerative bone disease and orthopaedic therapies through clinical development towards commercialisation. ... more

Autifony Therapeutics announces initiation of Phase IIa study for first-in-class drug to treat tinnitus

Autifony Therapeutics Limited, which is pioneering the development of novel pharmaceutical treatments for hearing disorders, announced that it has initiated a Phase IIa study in tinnitus subjects with its lead compound AUT00063. This proof of concept study (called the QUIET-1 study, QUest I ... more

Fat and bone marrow-derived stem cells combo shows promise in preventing transplant rejection

With more soldiers returning from combat suffering devastating injuries, doctors are turning to a reconstructive surgery that uses tissue transplantation along with immuno-suppression therapy.  This approach has had encouraging results; however, rejection of transplanted tissue from an unma ... more

Immunotherapy set to revolutionise cancer treatment

Immunotherapy is set to revolutionise the treatment of cancer, according to ESMO President Professor Rolf A. Stahel. His comments come as the ESMO Symposium on Immuno-Oncology 2014  is about to open in Geneva, Switzerland.“We expect that the new possibilities of immunotherapy will substanti ... more

The role DNA methylation plays in aging cells

Although every person's DNA remains the same throughout their lives, scientists know that it functions differently at different ages. As people age, drastic changes occur in their DNA methylation patterns, which are thought to act as a "second code" on top of the DNA that can lock genes in ... more

Clean energy 'bio batteries' a step closer

Researchers from the University of East Anglia (UEA) are a step closer to enhancing the generation of clean energy from bacteria. A report published shows how electrons hop across otherwise electrically insulating areas of bacterial proteins, and that the rate of electrical transfer is depe ... more

New insights from the Mouse ENCODE Project published in Genome Research

Genome Research publishes three articles in conjunction with articles published in other journals describing recent advances from the Mouse ENCODE Project Consortium. Initially launched to complement the human Encyclopedia of DNA Elements (ENCODE) Project in 2008, the Mouse ENCODE Project a ... more

All news on biotechnology

Thermo Fisher Scientific and Samsung Electronics to Collaborate on Point-of-Care Diagnostic Solutions

To answer the healthcare industry’s demand for better point-of-care (POC) diagnostics, Thermo Fisher Scientific Inc. and Samsung Electronics Co., Ltd. have formed a strategic collaboration. The companies will jointly design, develop and market new POC solutions in key applications, such as ... more

Towards future lab-on-chip applications

Smart and portable medical equipment is essential for fast and easy point-of-care and point-of-use diagnostics. Lab-on-a-chip applications in hand-held devices can help to save time for laboratory medical analysis in emergency scenarios. The combination of sub-micrometer-thick light emittin ... more

Humedics closes 6.3 million € financing round

Humedics GmbH announced the closing of a Series C financing round totaling more than 6.3 million Euro. Humedics’ business model, products and company development has attracted new international investors that will join the current private and public investors.The financing round was led by ... more

Failed Alzheimer’s test shows in which direction the research should continue

Disappointing results in clinical Alzheimer’s studies discourage doctors and scientists from continuing their research into ɣ-secretases and a possible treatment against Alzheimer’s disease. In Cell, the Alzheimer’s expert Bart De Strooper (VIB-KU Leuven) argues that these studies are not p ... more

bioLytical develops 60-second Ebola testing kit

bioLytical Laboratories has successfully developed a pre-clinical prototype diagnostic test for the rapid detection of antibodies to the Ebola Zaire strain responsible for the current outbreak in West Africa. The prototype is based upon the Company's proven, accurate, and highly accepted IN ... more

Ventana announces collaboration to develop companion diagnostics for ImmunoGen's targeted anticancer agents

Ventana Medical Systems, Inc. announced it has entered into an agreement with ImmunoGen, Inc. to collaborate on the development of biomarker assays and a companion diagnostic immunohistochemistry (IHC) test for one or more of ImmunoGen's product candidates. Under this agreement, the compani ... more

QIAGEN announces broad agreement with Astellas Pharma to develop companion diagnostics

QIAGEN N.V.  announced a master collaboration agreement with Astellas Pharma Inc. to develop and commercialize companion diagnostics paired with Astellas drugs for use in cancer and other diseases. The scope of the agreement is not restricted to certain sample types, platforms, indications ... more

Preventing Shock

Clinical shock is one of the most common causes of the high mortality rate among critically-ill patients in Intensive Care Units. During shock, the transport of oxygenated blood is not sufficient to meet the metabolic demands of the tissue. Early detection is important as shock-preventing m ... more

Earlier unknown molecular-level mechanism may contribute to the growth rate of breast cancer

Researchers at VTT Technical Research Centre of Finland, the University of Turku and the University of Oslo have discovered a previously unknown molecular-level mechanism that may partly explain the increased growth of cancer cells. The study, published in the British Journal of Cancer, sho ... more

New clues for the early detection of colorectal cancer

Researchers at the University of Luxembourg have identified potential new ways to test for the first signs of one of the most deadly types of cancer: colorectal cancer. They have found new “biomarkers”: molecules whose increased presence or absence in tissue suggests the development of tumo ... more

All news on diagnostics

Expansion of the WALDNER Group

The WALDNER Group, with its headquarters in Wangen, and Hohenloher Spezialmöbelwerke have joined forces on the market for laboratory furniture and furniture for scientific classrooms. Both corporations can look back on a tradition of more than 100 years. Waldner (approx. 1100 employees) is ... more

LAUDA founds subsidiary in Italy

The constant temperature equipment specialist LAUDA is expanding its international reach with the creation of LAUDA Italia. The purpose of the 100% subsidiary of LAUDA Beteiligungs-GmbH is to manage the increased expansion of business in the important European market. "In this company decis ... more

analytica China 2014: Closed with overall success

On September 26 analytica China 2014 closed with record-breaking visitor numbers: 18,775 business professionals (2012: 16,940) from 62 countries attended the seventh edition of Chinas Leading Trade Fair for Laboratory Technology, Analysis, Biotechnology and Diagnostics at the Shanghai New I ... more

Messe München International takes over one of India's leading trade fairs for laboratory technology

Messe München International is strengthening its portfolio of events in the future market of India by taking over India Lab Expo, one of the leading trade fairs for laboratory technology, analysis and biotechnology on the Indian subcontinent. For the first time ever, this year's India Lab E ... more

Bochem Increasingly Using New Media

Bochem Instrumente GmbH presents sections of its overall product spectrum in various new videos. The recently finished productions provide a compact overview of the product groups of lab jacks, electrical lifts, containers as well as stands and clamps. They can be found on the company’s web ... more

Merger of CyBio AG into Analytik Jena AG Completed

The merger of CyBio AG into Analytik Jena AG became effective upon entry into the commercial register of Analytik Jena AG (commercial register of the Registry Court of Jena, HRB 200027). As a result, CyBio AG is dissolved as an independent company. In the future, the Life Science business u ... more

LABVOLUTION – the new lab technology show in Hannover

Deutsche Messe is launching LABVOLUTION, a new trade fair to be staged every two years as amajor platform for the world of lab technology and equipment. LABVOLUTIONmakes its debut from 6 to 8 October 2015 at the Hannover Exhibition Center in Hannover, Germany, where it will take place every ... more

Automating Laboratory-On-A-Chip To Cut Healthcare Costs

A research team at the University of California, Riverside has created a computer programming language that will automate “laboratory-on-a-chip” technologies used in DNA sequencing, drug discovery, virus detection and other biomedical applications.“If you think of the beginning of computers ... more

Reorganization of the Executive Board of Eppendorf AG

The Executive Board of Eppendorf AG is reshaping in order to be optimally equipped to meet the future demands of the market. Dr. Dirk Ehlers, Chairman of the Executive Board of the Eppendorf Group, will leave the company by mutual agreement. Detmar Ammermann (Chief Financial Officer) will r ... more

New microscope sees what others can't

Microscopes don't exactly lie, but their limitations affect the truths they can tell. For example, scanning electron microscopes (SEMs) simply can't see materials that don't conduct electricity very well, and their high energies can actually damage some types of samples. In an effort to ext ... more

All news on lab technology

Long-Term Testosterone Therapy Does Not Increase the Risk of Prostate Cancer

Testosterone (T) therapy is routinely used in men with hypogonadism, a condition in which diminished function of the gonads occurs. Although there is no evidence that T therapy increases the risk of prostate cancer (PCa), there are still concerns and a paucity of long-term data. In a new st ... more

$1 Billion Oncology Alliance Initiates First-in-Human Study of Enhanced Antibody for Treatment of Acute Myeloid Leukemia

Oxford BioTherapeutics and Berlin Chemie/ Menarini Biotech/ Menarini Ricerche (belonging to Menarini Group) announced that they have initiated the first-in-human clinical study of OBT357 (MEN1112), an enhanced antibody for the treatment of acute myeloid leukemia (AML). This is the first of ... more

Merck Commissions Biomass Energy Plant in India

Merck commissioned a climate-neutral co-generation plant at its production site in Goa, India. In doing so, Merck is underscoring its commitment to climate protection and energy efficiency in line with its corporate responsibility. The project is part of a company-wide climate protection pr ... more

Apitope Receives Orphan Designation in the European Union for ATX-F8-117 for the treatment of Haemophilia A

Apitope announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) has granted orphan medicinal product designation to ATX-F8-117 for the treatment of haemophilia A.Haemophilia A is a rare chronic bleeding disorder which leads to inadequate clotting of ... more

PSR-Agility Wins Second Consecutive ROAR Award for “Best Orphan Drug CRO”

The PSR-Agility Orphan Drug Development partnership has for the second consecutive year been awarded “Best Orphan Drug Contract Research Organisation” in the Rare & Orphan Advocacy and Research (ROAR) Awards.The ROAR Awards were announced during the 5th Annual World Orphan Drug Congress Eur ... more

Onxeo announces positive DSMB recommendation for its Phase III trial with Livatag in primary liver cancer

Onxeo SA announced that the European Independent Board of Experts (Data Safety and Monitoring Board, DSMB) in charge of the safety monitoring of the Livatag® Phase III trial has once again unanimously recommended continuing the study without modification."Each new positive recommendation fr ... more

Precisely off the mark: Possible Cause Discovered For Failure of Targeted Liver Cancer Therapies

The failure of experimental liver cancer therapies directed specifically against the EGFR protein is presumably the result of insufficiently specific patient selection. This is the conclusion that can be drawn from data that were obtained within the framework of a project carried out by an ... more

Cerdelga recommended for approval in type 1 Gaucher disease

The European Medicines Agency (EMA) has recommended granting a marketing authorisation in the European Union (EU) for Cerdelga (eliglustat), for the treatment of type 1 Gaucher disease, a rare, debilitating and life-threatening genetic disease.Gaucher disease is estimated to affect approxim ... more

Heptares Orphan Disease Programme awarded grant from the UK Biomedical Catalyst

Heptares Therapeutics announced that it has been awarded a £1.5 million grant from the UK Biomedical Catalyst, a funding programme jointly operated by the UK Medical Research Council (MRC) and Innovate UK. The grant, with additional funding from Heptares, will support a three-year research ... more

BASF divests Omega-3 production plant

BASF has signed a definitive agreement to sell its manufacturing facility for natural fish oils, medium-concentrated omega-3s, and customized bottled fish oil in Brattvåg, Norway, to Marine Ingredients, a leading manufacturer of quality marine-based ingredients and customized products. Both ... more

All news on pharma

Long-Term Testosterone Therapy Does Not Increase the Risk of Prostate Cancer

Testosterone (T) therapy is routinely used in men with hypogonadism, a condition in which diminished function of the gonads occurs. Although there is no evidence that T therapy increases the risk of prostate cancer (PCa), there are still concerns and a paucity of long-term data. In a new st ... more

Aluminium in everyday life: a health risk?

Aluminium and its compounds are contained in numerous foods, cosmetics and other products. Scientists, the media and the public are currently debating whether there may be a connection between aluminium intake and diseases such as Alzheimer's and breast cancer. Does aluminium indeed cause i ... more

SLU researcher finds an off switch for pain

In research published in the medical journal Brain, Saint Louis University researcher Daniela Salvemini, Ph.D. and colleagues within SLU, the National Institutes of Health (NIH) and other academic institutions have discovered a way to block a pain pathway in animal models of chronic neuropa ... more

Trojan horse tactic gives parasites edge over immune systems

Parasites use Trojan horse subterfuge to suppress the immunity of their victims when causing infection, according to a study. The finding, which shows a new trick parasites can play, paves the way to possible treatments for infectious diseases and allergies. Scientists have shown that paras ... more

Has a possible new lead been found in the fight against neurodegenerative diseases?

Good communication between brain cells is vital for optimal (mental) health. Mutations in the TBC1D24 gene inhibit this process, thereby causing neurodegeneration and epilepsy. Fruit flies with a defect in Skywalker, the fruit fly variant of TBC1D24, are being used as a model for neurodegen ... more

Precisely off the mark: Possible Cause Discovered For Failure of Targeted Liver Cancer Therapies

The failure of experimental liver cancer therapies directed specifically against the EGFR protein is presumably the result of insufficiently specific patient selection. This is the conclusion that can be drawn from data that were obtained within the framework of a project carried out by an ... more

Immunotherapy set to revolutionise cancer treatment

Immunotherapy is set to revolutionise the treatment of cancer, according to ESMO President Professor Rolf A. Stahel. His comments come as the ESMO Symposium on Immuno-Oncology 2014  is about to open in Geneva, Switzerland.“We expect that the new possibilities of immunotherapy will substanti ... more

Antibiotics get a “time-out”

Resistance to antibiotics is an important health concern that affects both the spread of infections, like Clostridium difficile, and the medication budget. Researchers at the McGill University Health Centre (MUHC) examined the effectiveness of adopting an antibiotic “time-out” during treatm ... more

New insights that link Fragile X Syndrome (FXS) and Autism Spectrum Disorders (ASD)

Fragile X syndrome (FXS) is the most common cause of inherited intellectual disability (ID), as well as the most frequent monogenic cause of autism spectrum disorders (ASD). FXS is caused by the absence or incorrect production of the protein FMRP (Fragile X Mental Retardation Protein). Scie ... more

Monitoring Ebola cases in real-time

The current Ebola epidemic has shown how quickly a virus outbreak can turn into a global health crisis. To support of the fight against this epidemic, the German Centre for Infection Research (DZIF) just initiated the "EBOKON" consortium, which aims to promote Ebola research and close gaps ... more

All news on healthcare
News by department
News according to country
Companies in the news
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE